Ginkgo Bioworks Completes Acquisition of Zymergen : vimarsan

/PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that Ginkgo has...

Related Keywords

Boston , Massachusetts , United States , Jason Kelly , Securities Exchange , Nasdaq , Ginkgo Bioworks , Ginkgo Class , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports ,